Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul;5(3):163-172.
doi: 10.1097/FM9.0000000000000167. Epub 2022 Sep 14.

Expression of Key Steroidogenic Enzymes in Human Placenta and Associated Adverse Pregnancy Outcomes

Affiliations

Expression of Key Steroidogenic Enzymes in Human Placenta and Associated Adverse Pregnancy Outcomes

Jiasong Cao et al. Matern Fetal Med. 2023 Jul.

Abstract

Steroid hormones, including progestagens, estrogens, androgens, corticosteroids, and their precursor cholesterol, perform essential functions in the successful establishment and maintenance of pregnancy and normal fetal development. As the core endocrine organ at the prenatal stage, the human placenta is involved in the biosynthesis, metabolism, and delivery of steroid hormones. Steroidogenic pathways are tightly regulated by placenta-intrinsic cytochrome P450 and hydroxysteroid dehydrogenase. However, the relationship between placental steroidogenic enzyme expression and adverse pregnancy outcomes is controversial. In this review, we summarize the possible upstream regulatory mechanisms of placental steroidogenic enzymes in physiologic and pathophysiologic states. We also describe the human placental barrier model and examine the potential of single-cell sequencing for evaluating the primary functions and cellular origin of steroidogenic enzymes. Finally, we examine the existing evidence for the association between placental steroidogenic enzyme dysregulation and adverse pregnancy outcomes.

Keywords: Cytochrome P450; Hydroxysteroid dehydrogenase; Maternal-fetal outcomes; Placenta; Steroidogenic enzymes.

PubMed Disclaimer

Conflict of interest statement

None.

References

    1. Arabin B, Baschat AA. Pregnancy: an underutilized window of opportunity to improve long-term maternal and infant health—an appeal for continuous family care and interdisciplinary communication. Front Pediatr 2017;5:69. doi: 10.3389/fped.2017.00069. - DOI - PMC - PubMed
    1. Bangma JT Hartwell H Santos HP Jr., et al. Placental programming, perinatal inflammation, and neurodevelopment impairment among those born extremely preterm. Pediatr Res 2021;89(2):326–335. doi: 10.1038/s41390-020-01236-1. - DOI - PMC - PubMed
    1. Bokslag A van Weissenbruch M Mol BW, et al. Preeclampsia; short and long-term consequences for mother and neonate. Early Hum Dev 2016;102:47–50. doi: 10.1016/j.earlhumdev.2016.09.007. - DOI - PubMed
    1. Noyola-Martínez N, Halhali A, Barrera D. Steroid hormones and pregnancy. Gynecol Endocrinol 2019;35(5):376–384. doi: 10.1080/09513590.2018.1564742. - DOI - PubMed
    1. Payne AH, Hales DB. Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. Endocr Rev 2004;25(6):947–970. doi: 10.1210/er.2003-0030. - DOI - PubMed

LinkOut - more resources